SCHEMBL13733916

SCHEMBL13733916

O=C(O)N1CC2NC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20298564 0.82 CHRNB2 (0.34) —
SCHEMBL20298601 0.82 CHRNB2 (0.34) —
Hydrochloric Acid SCHEMBL20298582 0.80 CHRNB2 (0.33) —
SCHEMBL29497583 0.79 — —
SCHEMBL18705654 0.76 CHRNB2 (0.62) —
SCHEMBL19456202 0.76 — —
SCHEMBL15819325 0.74 CHRNB2 (0.38) —
SCHEMBL19948600 0.74 CHRNB2 (0.61) —
SCHEMBL21543557 0.74 CHRNB2 (0.38) —
SCHEMBL1404444 0.74 CHRNB2 (0.61) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269725-B Anti-influenza virus compound, preparation method and application thereof 西藏海思科制药有限公司 2024-09-17 — — CN disclosed
EP-4395892-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2024-07-10 — — EP disclosed
US-20140066369-A1 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2014-03-06 — — US disclosed
WO-2012145361-A1 MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2012-10-26 — — WO disclosed
Send feedback